Zobrazeno 1 - 1
of 1
pro vyhledávání: '"B D, Lovasz"'
Autor:
L S, Kiss, T, Szamosi, T, Molnar, P, Miheller, L, Lakatos, A, Vincze, K, Palatka, Z, Barta, B, Gasztonyi, A, Salamon, G, Horvath, G T, Tóth, K, Farkas, J, Banai, Z, Tulassay, F, Nagy, M, Szenes, G, Veres, B D, Lovasz, Z, Vegh, P A, Golovics, M, Szathmari, M, Papp, P L, Lakatos
Publikováno v:
Alimentary pharmacologytherapeutics. 34(8)
Adalimumab is a fully human monoclonal antibody targeting tumour necrosis factor with proven efficacy in the treatment of Crohn's disease (CD).To investigate the predictors of medium-term clinical efficacy and mucosal healing during adalimumab therap